FDA Clearance Tracker · K123213
BD PHASEAL CLOSED SYSTEM TRANSFER DEVICE
Last checked: Nov 20, 2026Latest source record: Jan 9, 2013 (this decision)Source: openFDAMethods & limitations
Decided
Jan 9, 2013
Substantially Equivalent
Time to decision
86 days
Received Oct 15, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K123213
- Device name
- BD PHASEAL CLOSED SYSTEM TRANSFER DEVICE
- Applicant
- Becton, Dickinson & CO
- Applicant location
- Franklin Lakes, NJ
- Received
- Oct 15, 2012
- Decided
- Jan 9, 2013
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 880.5440
- Specialty
- Hospital Medicine & Nursing
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code ONB (Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K123213
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Becton, Dickinson & CO
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K160164 · Decided Feb 25, 2016 · 29 days after receipt
Device type: Devices Detecting Influenza A, B, And C Virus Antigens (PSZ) · Laboratory Medicine & Pathology
K160161 · Decided Feb 24, 2016 · 28 days after receipt
Device type: Devices Detecting Influenza A, B, And C Virus Antigens (PSZ) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.